Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Wieslawa K. Giermakowska"'
Autor:
Ronald B. Moss, Dennis J. Carlo, Fred C. Jensen, Jay R. Savary, Wieslawa K. Giermakowska, Mark R. Wallace
Publikováno v:
AIDS. 14:2475-2478
OBJECTIVE We hypothesized that cell mediated immune responses to an HIV-1 immunogen (whole-killed, gp120-depleted HIV-1 in IFA, REMUNE) would include those to autologous virus. METHODS Five chronically HIV-1 infected individuals were examined for HIV
Autor:
Georgia Theofan, Mark R. Wallace, Fred C. Jensen, Jay R. Savary, Steven P. Richieri, Erin Webb, Ronald B. Moss, Dennis J. Carlo, Carolyn Chamberlin-Brandt, Roy Musil, Wieslawa K. Giermakowska
Publikováno v:
The Journal of Infectious Diseases. 180:641-648
It was hypothesized that immune recognition could be stimulated with combined immune-based and potent antiviral drug therapies. This study examined human immunodeficiency virus type 1 (HIV-1)-specific lymphocyte proliferation before and after treatme
Autor:
Paola Lanza, Peter L. Salk, Richard B. Hancock, Fred C. Jensen, Wieslawa K. Giermakowska, Dennis J. Carlo, Ronald B. Moss, Steven P. Richieri, Georgia Theofa
Publikováno v:
Vaccine. 16:727-731
In this study, the effects were examined of dose and adjuvant of a whole-killed gp120-depleted HIV-1 antigen on antibody and cytokine responses in a murine model. Immunization with increasing doses of inactivated HIV-1 antigen in Incomplete Freund's
Autor:
Anne E. Daigle, Steven P. Richieri, Richard J. Trauger, Wieslawa K. Giermakowska, Georgia Theofan, Dennis J. Carlo, Ronald B. Moss, John Turner, Francois Ferre, Chris Duffy, Fred C. Jensen, Mark R. Wallace
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14:343-350
OBJECTIVE To measure beta-chemokine and cytokine production in HIV-1-infected subjects undergoing treatment with HIV-1 immunogen (REMUNE). DESIGN Open label treatment study. METHODS beta-Chemokine and cytokine production in peripheral blood mononucle
Autor:
Carolyn Brandt, Mark R. Wallace, Dennis J. Carlo, Ronald B. Moss, Wieslawa K. Giermakowska, Georgia Theofan, Jay R. Savary, Maurizio Zanetti
Publikováno v:
Vaccine. 21(11-12)
The immunologic correlates associated with control of viremia in HIV disease are poorly understood. We hypothesized that structured antiviral drug treatment interruptions could be utilized to better understand the relationship between HIV-specific im
Autor:
Dennis J. Carlo, Mark R. Wallace, Wieslawa K. Giermakowska, Fred C. Jensen, Ronald B. Moss, Jay R. Savary
Publikováno v:
Clinical and diagnostic laboratory immunology. 7(5)
The discovery of multiple subtypes of human immunodeficiency virus type 1 (HIV-1) worldwide has created new challenges for the development of both therapeutic and preventive AIDS vaccines. We examined T-helper proliferative responses to HIV-1 clade A
Autor:
Dennis J. Carlo, Fred C. Jensen, Mark R. Wallace, Ronald B. Moss, Wieslawa K. Giermakowska, Erin Webb, Jay R. Savary
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 24(3)
OBJECTIVE We hypothesized that treatment of HIV-1-seropositive study subjects receiving potent antiviral therapy with an HIV-specific immune-based therapy would increase HIV-1-specific T-helper immune function. DESIGN 10 HIV-1-seropositive study subj
Autor:
Dennis J. Carlo, Steven P. Richieri, Carolyn J. Chamberlin, Ronald B. Moss, Georgia Theofan, Mark R. Wallace, Wieslawa K. Giermakowska, Fred C. Jensen, Paola Lanza
We examined the effect of immune stimulation by a human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) compared to a non-HIV vaccine (influenza) on HIV-1-specific immune responses in HIV-1-seropositive subjects. HIV-1 p24 antigen-stimulated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2b6ed83d29e1fa99d81eb2a24dc1352
https://europepmc.org/articles/PMC104515/
https://europepmc.org/articles/PMC104515/
Autor:
Anne E. Daigle, Wieslawa K. Giermakowska, Georgia Theofan, Richard J. Trauger, Paola Lanza, Fred C. Jensen, Steven W. Brostoff, Ronald B. Moss, Francois Ferre, Dennis J. Carlo, Steven P. Richieri
Publikováno v:
Journal of biomedical science. 4(4)
The impairment of lymphocytes to proliferate to HIV antigen is a relatively early functional defect of cell-mediated immunity found in HIV-infected individuals. The finding of strong proliferative responses in nonprogressive HIV disease as well as it
Autor:
Fred C. Jensen, Steven P. Richieri, Ronald B. Moss, Georgia Theofan, Mark R. Wallace, Dennis J. Carlo, John Turner, Wieslawa K. Giermakowska, Paola Lanza
Publikováno v:
Viral immunology. 10(4)
Lymphocyte proliferation responses to gp120-depleted HZ321 virus (clade A) antigen were compared to BAL human immunodeficiency virus (HIV) virus antigen (clade B) responses, clade E HIV virus antigen responses, and purified native p24 antigen respons